OTC · HGENQ
Humanigen, Inc.
$0.00$0.00 (0.0%)
Humanigen, Inc.: Healthcare · Biotechnology.
Loading market information…
OTC · QSAM · USD
Stock price, earnings
Quote as of May 2, 2024, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
QSAM Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.95% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow QSAM Biosciences, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Austin, Texas, QSAM Biosciences, Inc. is dedicated to advancing nuclear medicine for cancer and related illnesses. A key component of their pipeline is CycloSam (Samarium-153 DOTMP), a radiopharmaceutical currently in clinical development that specifically targets bone. The company holds a licensing agreement with IGL Pharma, Inc. Founded in 2004, the organization operated as Q2Earth, Inc. before rebranding to QSAM Biosciences, Inc. in September 2020.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Humanigen, Inc.: Healthcare · Biotechnology.
$1.01$0.00 (0.0%)
Cantabio Pharmaceuticals, Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Diagnocure, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
NMC Health plc’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
NutraLife BioSciences, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Navidea Biopharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.77% below the high.
$0.01$0.00 (0.0%)
NeonMind Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
$0.00$0.00 (0.0%)
Rapid Therapeutic Science Laboratories, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.29% below the high.
